Table 1.
Demographic characteristics of the study population, ART‐CC
| Overall (N=124,587) | |
|---|---|
| Age (years)‐median (IQR) | 38 (32 to 46) |
| Male sex | 95,001 (76%) |
| Year of ART initiation‐median (IQR) | 2005 (2001 to 2009) |
| Baseline ART regimen | |
| NNRTI | 49,936 (40%) |
| PI | 64,306 (52%) |
| Other | 10,345 (8%) |
| ADE at or prior to baseline | 24,849 (20%) |
| Transmission risk | |
| Heterosexual | 43,644 (35%) |
| MSM | 43,387 (35%) |
| IDU | 15,347 (12%) |
| Blood transfusion | 980 (1%) |
| Other/unknown | 21,229 (17%) |
| Baseline CD4+ count (cells/ml), median (IQR) | 244 (117 to 369) |
| Baseline HIV‐1 RNA (copies/ml), median (IQR) | 66,580 (14,000 to 200,000) |
| Years of follow‐up, median (IQR) | 5.18 (2.28 to 9.42) |
ADE, AIDS‐Defining Event; IQR, interquartile range; ART, antiretroviral therapy; PI, protease inhibitor; NNRTI, non‐nucleoside reverse transcriptase inhibitor; HIV, human immunodeficiency virus; MSM, male‐male sexual contact; IDU, injection drug use; ml, millilitre.